BRIDGEWATER, N.J.--(BUSINESS WIRE)--NovaDel Pharma Inc. (OTCBB: NVDL) (the “Company”), a specialty pharmaceutical company developing oral spray formulations for a broad range of marketed treatments, reported financial results for its first quarter ended March 31, 2010. For the quarter ended March 31, 2010, NovaDel reported a net loss of $1.3 million, or $0.01 per share compared to a net loss of $2.1 million, or $0.04 per share for the quarter ended March 31, 2009. As of March 31, 2010, the Company’s cash and cash equivalents were $3.7 million.
